NasdaqGM - Nasdaq Real Time Price USD

Neurogene Inc. (NGNE)

14.77
-0.23
(-1.57%)
As of 2:09:31 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
925
925
0
0
0
Operating Expense
83,530
83,530
55,583
56,517
50,534
Operating Income
-82,605
-82,605
-55,583
-56,517
-50,534
Net Non Operating Interest Income Expense
8,455
8,455
2,939
1,335
17
Other Income Expense
-994
-994
16,327
-7
--
Pretax Income
-75,144
-75,144
-36,317
-55,189
-50,517
Net Income Common Stockholders
-75,144
-75,144
-36,317
-55,189
-50,517
Diluted NI Available to Com Stockholders
-75,144
-75,144
-36,317
-55,189
-50,517
Basic EPS
-4.28
--
-73.83
-37.80
-34.60
Diluted EPS
-4.28
--
-73.83
-37.80
-34.60
Basic Average Shares
17,567.08
--
491.87
1,459.98
1,459.98
Diluted Average Shares
17,567.08
--
4,656.95
1,459.98
1,459.98
Total Operating Income as Reported
-82,605
-82,605
-55,583
-56,517
-50,534
Total Expenses
83,530
83,530
55,583
56,517
50,534
Net Income from Continuing & Discontinued Operation
-75,144
-75,144
-36,317
-55,189
-50,517
Normalized Income
-75,718
-75,718
-52,672
-55,189
-50,517
Interest Income
8,467
8,467
2,951
1,337
17
Interest Expense
12
12
12
2
0
Net Interest Income
8,455
8,455
2,939
1,335
17
EBIT
-75,132
-75,132
-36,305
-55,187
-50,517
EBITDA
-71,885
-71,885
-33,008
-51,987
-49,570
Reconciled Depreciation
3,247
3,247
3,297
3,200
947
Net Income from Continuing Operation Net Minority Interest
-75,144
-75,144
-36,317
-55,189
-50,517
Total Unusual Items Excluding Goodwill
574
574
16,355
0
--
Total Unusual Items
574
574
16,355
0
--
Normalized EBITDA
-72,459
-72,459
-49,363
-51,987
-49,570
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 3/7/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

TSHA Taysha Gene Therapies, Inc.
2.1350
+1.67%
 
LXEO Lexeo Therapeutics, Inc.
2.8300
-5.67%
 
DYN Dyne Therapeutics, Inc.
11.59
+2.61%
 
ALSEN.PA Sensorion SA
0.4000
+2.30%
 
MBX MBX Biosciences, Inc.
10.95
-6.46%
 
DSGN Design Therapeutics, Inc.
3.4220
-2.78%
 
SRRK Scholar Rock Holding Corporation
30.76
-0.74%
 
KRRO Korro Bio, Inc.
15.65
+1.62%
 
TRVI Trevi Therapeutics, Inc.
6.63
+0.38%
 
MLYS Mineralys Therapeutics, Inc.
14.71
-5.77%